ArticleExperimental and therapeutic medicine2018

Decreased expression of microRNA-214 contributes to imatinib mesylate resistance of chronic myeloid leukemia patients by upregulating ABCB1 gene expression.

Jing Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.